Maternal iron‐deficiency anaemia at term (Hb less than 110 g/L and at least 1 additional laboratory indicators at 37 weeks' gestation or more) · Women receiving supplements in pregnancy
It is very uncertain whether any intermittent iron regimen (with or without other vitamins and… changes maternal iron‐deficiency anaemia at term (Hb less than 110 g/L and… compared with daily regimen (with same vitamins and minerals)‐maternal outcomes (very low certainty).
1 finding from 1 review
ANC coverage: four or more visits · pregnant women
One intervention leads to higher ANC coverage: four or more visits compared with no intervention (high certainty).
1 finding from 1 review
ANC coverage: one or more visits · pregnant women
Combination of interventions probably leads to higher ANC coverage: one or more visits compared with no intervention (moderate certainty).
1 finding from 1 review
ANC coverage: one or more visits · pregnant women
One intervention probably leads to higher ANC coverage: one or more visits compared with no intervention (moderate certainty).
1 finding from 1 review
ANC coverage: four or more visits · pregnant women
Combination of interventions showed no clear difference in ANC coverage: four or more visits compared with no intervention (low certainty).
1 finding from 1 review
Maternal anaemia at term or near term (haemoglobin (Hb) less than 110 g/L at 34 weeks' gestation or more) · women during pregnancy
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Maternal iron deficiency at term or near term (as defined by authors of the trials, based on any indicator of iron status at 34 weeks' gestation or more) · women during pregnancy
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Maternal anaemia at term or near term (haemoglobin (Hb) less than 110 g/L at 34 weeks' gestation or more) · women during pregnancy
1 finding from 1 review
no estimate extracted
470 participants
Very low
Maternal iron deficiency at term or near term (as defined by authors of the trials, based on any indicator of iron status at 34 weeks' gestation or more) · women during pregnancy
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Recurrent pyelonephritis · pregnant women with a history of one or more UTI before or during pregnancy
It is very uncertain whether nitrofurantoin and close surveillance changes recurrent pyelonephritis compared with close surveillance alone (very low certainty).
1 finding from 1 review
Recurrent UTI (cystitis) · pregnant women with a history of one or more UTI before or during pregnancy
It is very uncertain whether nitrofurantoin and close surveillance changes recurrent UTI (cystitis) compared with close surveillance alone (very low certainty).
1 finding from 1 review
Preterm birth · pregnant women with a history of one or more UTI before or during pregnancy
It is very uncertain whether nitrofurantoin and close surveillance changes preterm birth (< 37 weeks) compared with close surveillance alone (very low certainty).
1 finding from 1 review
Birthweight < 2500 (g) · pregnant women with a history of one or more UTI before or during pregnancy
It is very uncertain whether nitrofurantoin and close surveillance changes birthweight < 2500 (g) compared with close surveillance alone (very low certainty).
1 finding from 1 review
Birthweight (g) · pregnant women with a history of one or more UTI before or during pregnancy
1 finding from 1 review
Apgar score less than 7 at 5 minutes · pregnant women with a history of one or more UTI before or during pregnancy
It is very uncertain whether nitrofurantoin and close surveillance changes five‐minute Apgar score < seven compared with close surveillance alone (very low certainty).
1 finding from 1 review
Miscarriage · pregnant women with a history of one or more UTI before or during pregnancy
It is very uncertain whether nitrofurantoin and close surveillance changes miscarriages compared with close surveillance alone (very low certainty).
1 finding from 1 review
Neonatal sepsis · Women with meconium‐stained amniotic fluid in labour, gestational age more than 24 weeks
Antibiotic showed no clear difference in neonatal sepsis compared with placebo (low certainty).
1 finding from 1 review
Chorioamnionitis · Women with meconium‐stained amniotic fluid in labour, gestational age more than 24 weeks
Antibiotic probably leads to lower chorioamnionitis compared with placebo (moderate certainty).
1 finding from 1 review
Postpartum endometritis · Women with meconium‐stained amniotic fluid in labour, gestational age more than 24 weeks
Antibiotic showed no clear difference in postpartum endometritis compared with placebo (low certainty).
1 finding from 1 review
Mortality and morbidity prior to discharge (Neonatal intensive care admissions) · Women with meconium‐stained amniotic fluid in labour, gestational age more than 24 weeks
Antibiotic showed no clear difference in mortality and morbidity prior to discharge (Neonatal intensive care… compared with placebo (low certainty).
1 finding from 1 review